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Abstract
Paralleled with the rapid socio-economic development and demographic transition, an epidemic of non-
communicable chronic diseases (NCDs) has emerged in China over the past three decades, resulting in increased
disease and economic burdens. Over the past decade, with a political commitment of implementing universal
health coverage, China has strengthened its primary healthcare system and increased investment in public health
interventions. A community-based approach to address NCDs has been acknowledged and recognized as one of
the most cost-effective solutions. Community-based strategies include: financial and health administrative support;
social mobilization; community health education and promotion; and the use of community health centers in NCD
detection, diagnosis, treatment, and patient management. Although China has made good progress in developing
and implementing these strategies and policies for NCD prevention and control, many challenges remain. There
are a lack of appropriately qualified health professionals at grass-roots health facilities; it is difficult to retain
professionals at that level; there is insufficient public funding for NCD care and management; and NCD patients are
economically burdened due to limited benefit packages covering NCD treatment offered by health insurance
schemes. To tackle these challenges we propose developing appropriate human resource policies to attract greater
numbers of qualified health professionals at the primary healthcare level; adjusting the service benefit packages to
encourage the use of community-based health services; and increase government investment in public health
interventions, as well as investing more on health insurance schemes.
Introduction
Epidemiological, demographic and socio-economic transi-
tions in China over the past few decades have caused a
shift from communicable to non-communicable chronic
diseases (NCDs) [1]. In 2005, NCDs accounted for an
estimated 80% of deaths and 70% of disability-adjusted
life-years lost (DALY) in China [2]. In 2010, 34% of
Chinese adults over 18 years old (330 million) suffered
from hypertension and most were not on appropriate
blood pressure control medication [3]. About one-third
of Chinese people over 18 years old were overweight,
using Body Mass Index (BMI) over 24, and 12% were
categorized as obese (BMI≥28) in 2010 [4]. The proportion
of overweight adults from 18 to 64 years old increased
15% between 2007 and 2010, while the proportion of
obese adults increased by 57% during the same time inter-
val [4,5]. According to the World Health Organization
(WHO) Report of the Global Tobacco Epidemic in 2008,
over 300 million Chinese men were cigarette smokers and
100 million men currently under the age of 30 years will
die from tobacco use if such a smoking pattern continues
[6]. The prevalence and burden of NCDs in China will
continue to grow with a rapid aging population and
continuing changes in socio-economic development and
lifestyle choices which affect health. Collectively, these
pose great challenges to the improvement of health and
healthcare in China.* Correspondence: tangxiaoj0726@qq.com1School of Public Health and Management, Chongqing Medical University,
Chongqing, P.R. China
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China had a relatively well functioning health system
prior to the economic reform launched in the late 1970s.
It had faced numerous problems in financing of, and
access to, healthcare during the transformation from
planned to market economy in 1980s and 1990s. Since
the early 2000s, the Chinese government has renewed its
efforts to establish a functioning health system to ensure
adequate access to essential healthcare for the vast
majority of the Chinese population. Universal health
coverage is one important goal; ensuring all Chinese
people obtain the essential and affordable health services
they need without suffering financial hardship. This
requires a robust, efficient, and well-financed health
system with sufficient capacity, especially in terms of a
well-trained and motivated health workforce. It also
requires adequate financial protection for access to
medicines, technologies and other services.
With a political commitment to universal health cover-
age, over the past decade China has made notable
progress: more than 92% of the Chinese population is
covered by health insurance in 2011[7]; numerous public
health interventions launched to tackle both communic-
able diseases (such as HIV/AIDS, tuberculosis), and
NCDs (e.g., hypertension and Diabetes Mellitus (DM)),
and adequately funded and implemented community-
based health service delivery system being established; the
national essential medicine system strengthened to
improve rational use of medicines for better quality and
cost control, especially at the community level [7,8]; com-
munity health centers (CHCs) and community health
stations (CHSs) in urban areas; township health centers
(THCs) and village health stations (VHSs) in rural areas,
empowered to play a key role in improving equitable and
affordable access to essential healthcare for the popula-
tion. Furthermore, the government has developed and
implemented a series of measures to enhance the capacity
of service provision at these health facilities, including
construction and equipment standards for these health
facilities, the development of guidelines for general practi-
tioners, and training for primary healthcare providers.
There is also an increasing number of primary healthcare
facilities at grass-roots which now receive financial
supports from both central and local governments [7].
In spite of this progress in strengthening of the health
system, significant challenges remain in tackling NCDs in
China. With the exception of the Urban Employees’ Basic
Medical Insurance (UEBMI), many health insurance
schemes in China do not offer comprehensive coverage
of health services [7-9]. The service benefit packages
often prioritize inpatient services – as per the national
guidelines developed by the central government [7,10],
but most NCD patients require frequent uses of out-
patient services. For example, the New rural Cooperative
Medical Scheme (NCMS) and Urban Resident Basic
Medical Insurance (URBMI) - jointly financed by the
central and province government and with modest
premium contribution from individual members - often
do not adequately meet the needs of NCD patients.
Moreover, well-qualified doctors and nurses in China,
like elsewhere in the world, are less likely to work at
primary healthcare facilities, which may compromise the
quality of care at the community level.
This paper discusses and analyzes the progress and
challenges faced when implementing a community-based
approach for NCD care and management in the context
of advancing universal health coverage in China. First, we
discuss the burden of NCDs and challenges in managing
these conditions, using hypertension and DM as case
studies. Second, we analyze various health policy
initiatives related to NCD care and management at the
community level, in relation to health financing, and
health workforce. Finally, we offer suggestions regarding
the effectiveness of a community-based approach addres-
sing NCDs in China.
Burden of NCDs: challenges for China
Table 1 illustrates the rise of hypertension from 1958 to
2010, based on a series of nationwide epidemiological
surveys mainly undertaken by China Center for Disease
Control (CDC) [5,11-14]. While these data cannot be
directly compared due to differences in study designs and
measurements, rising hypertension rates in China are
strongly evident, and witnessed in various provinces and
cities. For example, Li and colleagues surveyed 16,364
rural residents over 25 years old in Shandong province
located in Eastern China in 2007 and reported an age-
standardized prevalence rate of hypertension of 37% [15].
In a less developed region Ningxia the prevalence rate
was 14% in the period of 2008-2009, reported by another
survey [16].
DM is another growing problem in China (Table 2)
[12,17-21]. In 2010 the estimated prevalence of diabetes
among a nationally representative sample of Chinese
adults was 12% and the estimated prevalence of pre-
diabetes was 50% [21].
The economic burden caused by both hypertension and
DM is heavy. According to the national data, 31.9 billion
and 10.7 billion Chinese yuan was spent on hypertension
and DM treatment in 2002, which accounted for 5.6%
and 1.9% of the total national health expenditure respec-
tively [22]. There was no reliable estimation of the eco-
nomic burden of hypertension and DM in recent years.
Strategies and policies for NCD prevention and
management in China
Most NCDs are associated with preventable risk factors.
Effective control of risk factors could reduce the incidence
of heart attack, stroke and DM by at least 80% [23].
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The incidence and prevalence of these diseases are closely
associated with income level, ecological environment, cul-
ture and lifestyle [1]. Recently, central and local govern-
ments in China have committed to develop and
implement a series of strategies including financial, techni-
cal and administrative support for NCD prevention and
treatment [24]. Table 3 introduces a number of these stra-
tegies and programs with associated indicators being used
to assess the effectiveness for these interventions.
Primary healthcare facilities at the community level
play a key role in the implementation of the strategies
and programs. They are mandated to provide essential
health services for every resident, especially children,
pregnant women, the elderly and patients with NCDs. In
2009, the government allocated 15 Chinese yuan per
person per year for the national public health interven-
tion programs; in 2011 the budget increased to 25
Chinese yuan per person per year [7]. In rural areas, 60%
of this funding was earmarked for township health
centers to implement public health interventions, while
the remaining 40% allocated to village health stations
[25]. Proportions of the total budget specifically for the
management of patients with hypertension and DM was
18% and 7%, respectively [25].
In recent year, China CDC issued the guidelines of
NCD prevention and treatment, advocating the integra-
tion of primary, secondary and tertiary prevention for
hypertension and DM at the primary healthcare level
[26,27]. Furthermore, the proposed guidelines tailored
interventions targeting three different population groups:
1) the general population; 2) high risk group with charac-
teristics of smoker and obesity, high blood pressure,
impaired glucose regulation and high hyperlipidemia; and
3) Hypertension and DM patients. For access of the
general population to primary healthcare, standardized
personal health profile should be established, containing
patient demographic, social characteristics, previous
medical records, family medical history, records of physi-
cal check-up, and life style, among others. In addition,
NCD related health education and promotion services
should be provided during outpatient visits to community
health centers and stations. Blood pressure should be
measured for those over 35 years and older. For the high
risk group, annual physical check-up is provided for early
detection of NCD patients. For Hypertensive and DM
patients, at least four follow-up visits per year can be
arranged, with free examinations and tests for blood pres-
sure or glucose. By the end of September 2011,




1958-1959 5.1 The national sampling survey with adults over 15 years Chinese guidelines revision committee of
prevention and treatment for hypertension, 2006
1979~1980 7.7
1991 13.6
2002 18.8 The national multistage and stratified sampling survey with adults
over 18 years
Li, 2005
2004 18.1 Multistage random sampling of adults aged at 18~69 years from
79-160 diseases surveillance sites
National center for NCD control and prevention
and China CDC, 2009
2007 24.9 National center for NCD control and prevention
and China CDC, 2010
2010 33.5 Li, 2012




1979 0.7 Random sampling in 14 provinces (cities) National Diabetes Prevention and Control Cooperative
Group, 1981
1994 2.5 Random sampling of adults aged at 24-64 years in 19 provinces
(cities)
Pan, 1997
1996 3.2 Stratified and cluster sampling of adults aged at 20~74years in 11
provinces (cities)
Wang, 1998
2000 6.4 Stratified and cluster sampling of adults aged at 35~74years in 10
provinces (cities)
Gu, 2003
2002 2.6 Multistage and stratified cluster sampling of adults over 18 years old
in 31provinces
Li, 2005
2010 11.6 Multistage, probability sampling in a nationally representative
sample ≥18years old
Xu, 2013
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433 million people have established their personal health
record cards, and more than 59 million hypertensive and
DM patients are now under the NCD case management
system in which community health centers and stations
in urban areas and township health centers and village
health stations in rural areas are key players for these dis-
ease prevention and control activities. Other government
strategies for prevention, treatment and management of
NCDs included the establishment of three national health
insurance schemes to facilitate access to clinical care -
the urban employee basic medical insurance (UEBMI),
urban resident basic medical insurance (URBMI) and
new rural cooperative medical scheme (NCMS). The Chi-
nese Ministry of Health also developed a national essen-
tial medicines list and relevant policies which encourage
the rational use of medicines at primary health facilities
at the community level.
Challenges in addressing NCDs for China
Despite the good progress made to control and prevent
NCDs, great challenges remain in China. One challenge is
poor knowledge and low awareness about NCDs,
particularly at the poor and rural community level. In
2010, only one quarter of DM patients in rural areas were
aware of their illness, compared to 40% among urban
patients; One fifth of rural patients and two fifths of urban
patients received treatment for diabetes [21]. A significant
disparity in awareness of NCDs was also found across dif-
ferent socio-economic development regions [21].
While the primary healthcare facilities at the community
level are at the center of NCD prevention and
management activities, the quantity and expertise of health
professionals at these facilities are far from optimal [28].
The total number of primary healthcare workers in urban
areas was about three million in 2011; about three quali-
fied doctors/assistants and 3.32 registered nurses per 1,000
population [29]. In rural areas, the ratio of qualified health
workers and registered nurses to 1,000 population was
only 1.32 and 0.98, respectively, in the same year [29].
Furthermore, the majority of health professionals in both
rural and urban primary healthcare facilities had only
2-3 years of medical education/training, and only 8% of
health professionals had a university/college degree. This
is due largely to the fact it is difficult to attract new
medical and public health graduates, and retain qualified
professionals in these facilities. Since the economic reform,
the income level of healthcare workers in China has been
closely linked with their capacity of revenue generation
through user fee charges. The sources of income for most
health professionals at the primary healthcare level have
often come from drug sales and provision of profitable
services. As part of the recent health system reform, the
government has now allocated more funds to primary
healthcare facilities to encourage the provision of quality
services. As a result of the reform, the income of health-
care professionals at this level has no longer been driven
by over-provision of drugs and services. The incomes of
these doctors and nurses have gradually increased, but still
remain relatively low [30]. In addition, opportunities for
career development and quality education for the children
of health professionals are important factors affecting their
preference to work in urban health facilities, instead of
rural ones [Liu, personal archive, 2013].
Existing health insurance policies in China also presents
great challenges in NCD care and management. The
service benefit packages offered by the main health insur-
ance schemes in urban and rural areas differ dramatically.
These schemes also tend to prioritize the coverage of
inpatient services, while the coverage of outpatient services
is either inadequate or lacking. These policies often do not
go far enough in meeting the treatment needs of NCD
patients in particular [10]. While the above-mentioned
three health insurance schemes cover 1.3 billion people -
over 90% of the total population in China - the reimburse-
ment rate for inpatient service expenditures by the new
rural cooperative medical scheme, for example, ranges
between 40- 70% in many regions [7]. The report on
chronic disease in China in 2006 shows, average expenses
Table 3 Strategies and programs for NCD prevention and management in China
Strategies Selected Public Health
Programs
Selected assessment indicators
• Financial support from each level government
• Advocacy and social mobilization to develop supportive
community environment for NCD prevention and control
• Community health education and promotion
• Clarification of NCD prevention and control responsibility by
different health facilities (e.g. CDC, NCD specialist, CHC etc.)
• Training health practitioners of CHCs on NCD diagnosis,
treatment and rehabilitation services
• Comprehensive control for multiple risk factors including health
guidance on diet, fitness activity and tobacco control etc.
• Promoting NCD patient self-management model and home
services by general practitioners
• Population-based public
health interventions:







- Four times follow up visits
- Health guidance
• Knowledge of population on NCDs: ≥ 70%
• Knowledge on blood pressure: ≥ 70%
• Knowledge on blood glucose: ≥ 30%
• Registration rates: hypertension and DM ≥ 60%
of local prevalence or national average level
• Management rate of chronic diseases:
hypertension ≥ 35%, DM ≥ 30%
• Control rate of chronic diseases: hypertension ≥
50%, DM ≥ 50%
CHCs: community health centers; CDC: center for disease control; DM: diabetics mellitus; NCD: non-communicable diseases
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per hospital admission for hypertension and DM was
4,338 Chinese Yuan and 5,276 Chinese Yuan, respectively,
accounting for 1.5 times and 1.8 times of average annual
per capita income of the rural residents, and for 46% and
56% of average annual per capita income of urban
residents, respectively [31]. In addition, the proportion of
NCMS reimbursement for outpatient service expense was
generally much lower than what was reimbursed for
inpatient service expenses. One study conducted in
Shandong and Ningxia found only around 10% of out-
patient service expenditure reimbursable in rural areas in
2006 [32]. As a result, the economic burden of healthcare
expenditure placed on NCD patients was pretty significant
that 14-15% of rural households with NCD patients spent
more than 40% of their non-food expenditure on chronic
disease treatment in 2006 [32], a threshold for catastrophic
health expenditure defined by WHO.
Way forward for a community-based approach to
NCD care and control in China
The World Bank (2011) has recently raised serious con-
cerns about epidemics of NCDs in China in its report
entitled “Toward a healthy and harmonious life in
China: Stemming the rising tide of NCDs”. It has pro-
posed a comprehensive strategy for addressing this
growing problem and tackling its challenges. As NCD
control requires a continuum of care and extensive
social support, a community-based approach has been
acknowledged as one of the most cost-effective preven-
tion and control measures [33]. We firmly believe that a
community-based approach helps to develop “early
detection, early diagnosis and early treatment and
systematic patient management”, as well as having
the added benefit of building a healthy and friendly
community environment through community advocacy
and participation, and helping to raise awareness and
knowledge of NCDs in the population [33].
For the community-based approach to NCD prevention
and control to be effective in China, we offer three
recommendations in this paper. First, China needs to
develop appropriate human resource policies to attract
more qualified health professionals to work at primary
health facilities, especially in rural areas. There have been
a number of experimental studies on how to retain quali-
fied health professionals in rural or remote areas.
Findings emanating from these studies indicate the need
to including both financial and non-financial incentives,
including policies on increasing income level, supporting
medical education, and providing more professional
career development opportunities. The government of
China needs to seriously consider the development of
appropriately tailored human resource policies that can
meet the needs of different local contexts.
Second, China needs to adjust the service benefit
packages offered by the health insurance schemes to be
in favor of the use of community-based health services.
China has achieved universal health insurance coverage,
but most schemes prioritize the coverage of inpatient
care because it was believed that expensive inpatient
care was the major reason for pushing people into pov-
erty. However, many studies in China and other coun-
tries have identified substantial costs incurred from
frequent outpatient visits for NCD treatments. That
financial burden has become a major factor resulting in
medical impoverishment [10,34]. Therefore, the design
of benefit packages should be re-visited and modified, as
strong evidence has arisen. A focus on prevention and
control of NCDs should also help to further mitigate
the medical and social costs of NCDs.
Lastly, China needs to continue to increase its invest-
ment in public health intervention programs and financial
support to health insurance schemes. Increased funding
from both central and local governments needs to be
directed to the less developed regions and poorer rural
areas to support NCD interventions, and health insurance
schemes. In addition, it is equally important to strengthen
monitoring of the use of funding for public health inter-
ventions, at the primary healthcare community level.
Finally, the population, especially the poor, needs to be
protected financially from high costs related to NCD
treatments.
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